Which laboratory value is considered critical for the administration of many chemotherapy agents?

Which laboratory value is considered critical for the administration of many chemotherapy agents?

• A. Platelet Count.
• B. Serum Creatinine Level.
• C. Absolute Neutrophil Count (ANC).
• D. Hemoglobin Concentration.

Answer: (C)

The absolute neutrophil count (ANC) is a critical laboratory value for the administration of many chemotherapy agents because it directly reflects the patient's ability to fight infections. Chemotherapy often leads to myelosuppression, which can significantly decrease the production of neutrophils, the white blood cells essential for combating bacteria and other pathogens. A low ANC indicates an increased risk of infection, and healthcare providers typically use this value to determine if it is safe to proceed with chemotherapy treatment. Most chemotherapy regimens require the ANC to be above a certain threshold to minimize the risk of severe neutropenia and its associated complications, such as fever and infections. Monitoring the ANC allows clinicians to make informed decisions about the timing of chemotherapy, potential dose adjustments, or the necessity of interventions like growth factor support to increase neutrophil production before treatment.

The absolute neutrophil count (ANC) is a critical laboratory value for the administration of many chemotherapy agents because it directly reflects the patient's ability to fight infections. Chemotherapy often leads to myelosuppression, which can significantly decrease the production of neutrophils, the white blood cells essential for combating bacteria and other pathogens.

A low ANC indicates an increased risk of infection, and healthcare providers typically use this value to determine if it is safe to proceed with chemotherapy treatment. Most chemotherapy regimens require the ANC to be above a certain threshold to minimize the risk of severe neutropenia and its associated complications, such as fever and infections.

Monitoring the ANC allows clinicians to make informed decisions about the timing of chemotherapy, potential dose adjustments, or the necessity of interventions like growth factor support to increase neutrophil production before treatment.